These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Jiang LQ; Jorquera M; Streilein JW Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3347-54. PubMed ID: 8225870 [TBL] [Abstract][Full Text] [Related]
5. Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Wenkel H; Streilein JW Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney. Ng TF; Osawa H; Hori J; Young MJ; Streilein JW J Immunol; 2002 Nov; 169(10):5601-6. PubMed ID: 12421938 [TBL] [Abstract][Full Text] [Related]
7. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation. Ishioka M; Okamoto S; Streilein JW; Jiang LQ Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279 [TBL] [Abstract][Full Text] [Related]
8. Unconventional rejection of neural retinal allografts implanted into the immunologically privileged site of the eye. Jiang LQ; Jorquera M; Streilein JW; Ishioka M Transplantation; 1995 Apr; 59(8):1201-7. PubMed ID: 7732567 [TBL] [Abstract][Full Text] [Related]
9. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants. Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290 [TBL] [Abstract][Full Text] [Related]
10. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts. Ma N; Streilein JW Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2384-93. PubMed ID: 9804147 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber. Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388 [TBL] [Abstract][Full Text] [Related]
12. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Sonoda Y; Sano Y; Ksander B; Streilein JW Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911 [TBL] [Abstract][Full Text] [Related]
13. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707 [TBL] [Abstract][Full Text] [Related]
14. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Sano Y; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710 [TBL] [Abstract][Full Text] [Related]
15. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Streilein JW; Ma N; Wenkel H; Ng TF; Zamiri P Vision Res; 2002 Feb; 42(4):487-95. PubMed ID: 11853765 [TBL] [Abstract][Full Text] [Related]
16. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space. Wenkel H; Chen PW; Ksander BR; Streilein JW Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943 [TBL] [Abstract][Full Text] [Related]